Pantoprazole Sodium Delayed-Release Tablets are indicated for short-term treatment of Erosive Esophagitis associated with GERD
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
The inspection of the facility conducted from August 7 to August 11, 2023
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Profit after tax (before exceptional items) up 23% to Rs 215 crores
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Subscribe To Our Newsletter & Stay Updated
